A Study Evaluating Safety and Pharmacokinetics of FPA144 in Japanese Patients With Advanced Gastric or Gastroesophageal Cancer

Summary

The main objectives of this study are: * To determine the recommended dose (RD) of FPA144 in participants with gastric or gastroesophageal cancer (hereafter referred to as gastric cancer) * To evaluate the safety of escalating doses of FPA144 in participants with gastric cancer * To characterize the pharmacokinetic (PK) profile of single and multiple doses of intravenously administered FPA144 in participants with gastric cancer

Timeline

Start

2017-06-12

Primary completion

2018-06-19

Completion

2018-06-19

Drugs

Indications